Effect of Glycemic Control on Platelet Indices in Children with Type 1 Diabetes Mellitus

Overview

Journal Sisli Etfal Hastan Tıp Bul

Specialty General Medicine

Date 2024 Jul 18

PMID 39021682

Authors

Kamile Yucel

Sekibe Isik Disci

Mehtap Yucel

Affiliations

Soon will be listed here.

Abstract

Objectives: The aim of this study is to compare children diagnosed with type 1 diabetes mellitus (T1DM) with healthy controls in terms of some laboratory parameters and platelet indices.

Methods: This study is retrospective. We used glycated hemoglobin (HbA1c) values to classify patients as <7% (good) and ≥7% (poor). The platelet mass (PM) value was calculated from the hemogram data (PM=PLTxMPV).

Results: The study included a total of 87 patients who had been diagnosed with T1DM and 120 healthy participants. Fasting glucose, urea, creatinine, hemoglobin (HGB), red blood cell (RBC), mean platelet volume (MPV) and platelet distribution width (PDW) were significantly higher in the patient group than in the healthy control group. Platelet (PLT), plateletcrit (PCT) and PM were significantly lower in the poor glycemic control than in the good glycemic control and healthy groups. The PDW in the healthy control group was statistically significantly lower than in the good and poor glycemic control groups. In the group with poor glycemic control, there was a positive and significant correlation between the MPV and the level of HbA1c (r=0.401, p<0.05).

Conclusion: To sum up, our results show that the MPV and the PDW are significantly higher in children with T1DM than in healthy control. In the group with poor glycemic control, PLT levels were significantly lower than in the other two groups, leading to a decrease in PCT and PM levels. Further studies are needed to understand whether the decrease in PLT levels is due to the hyperactivity and rapid turnover of PLT.

References

Tihic-Kapidzic S, causevic A, Foco-Solak J, Malenica M, Dujic T, Hasanbegovic S . Assessment of hematologic indices and their correlation to hemoglobin A1c among Bosnian children with type 1 diabetes mellitus and their healthy peers. J Med Biochem. 2021; 40(2):181-192. PMC: 7982283. DOI: 10.5937/jomb0-25315. View

Lipton R, Drum M, Danielson K, Greeley S, Bell G, Hagopian W . Onset features and subsequent clinical evolution of childhood diabetes over several years. Pediatr Diabetes. 2011; 12(4 Pt 1):326-34. PMC: 3103597. DOI: 10.1111/j.1399-5448.2010.00706.x. View

Szablewski L, Sulima A . The structural and functional changes of blood cells and molecular components in diabetes mellitus. Biol Chem. 2016; 398(4):411-423. DOI: 10.1515/hsz-2016-0196. View

Zaccardi F, Rocca B, Rizzi A, Ciminello A, Teofili L, Ghirlanda G . Platelet indices and glucose control in type 1 and type 2 diabetes mellitus: A case-control study. Nutr Metab Cardiovasc Dis. 2017; 27(10):902-909. DOI: 10.1016/j.numecd.2017.06.016. View

Venkatesh V, Kumar R, Varma D, Bhatia P, Yadav J, Dayal D . Changes in platelet morphology indices in relation to duration of disease and glycemic control in children with type 1 diabetes mellitus. J Diabetes Complications. 2018; 32(9):833-838. DOI: 10.1016/j.jdiacomp.2018.06.008. View

Panova-Noeva M, Schulz A, Hermanns M, Grossmann V, Pefani E, Spronk H . Sex-specific differences in genetic and nongenetic determinants of mean platelet volume: results from the Gutenberg Health Study. Blood. 2015; 127(2):251-9. DOI: 10.1182/blood-2015-07-660308. View

Alamri B, Bahabri A, Aldereihim A, Alabduljabbar M, Alsubaie M, Alnaqeb D . Hyperglycemia effect on red blood cells indices. Eur Rev Med Pharmacol Sci. 2019; 23(5):2139-2150. DOI: 10.26355/eurrev_201903_17259. View

Thompson C, Jakubowski J . The pathophysiology and clinical relevance of platelet heterogeneity. Blood. 1988; 72(1):1-8. View

Antar S, Ashour N, Sharaky M, Khattab M, Ashour N, Zaid R . Diabetes mellitus: Classification, mediators, and complications; A gate to identify potential targets for the development of new effective treatments. Biomed Pharmacother. 2023; 168:115734. DOI: 10.1016/j.biopha.2023.115734. View

10.

Han J, Choi D, Choi S, Kim B, Ki Y, Chung J . Stroke or coronary artery disease prediction from mean platelet volume in patients with type 2 diabetes mellitus. Platelets. 2012; 24(5):401-6. DOI: 10.3109/09537104.2012.710858. View

11.

Gkrania-Klotsas E, Ye Z, Cooper A, Sharp S, Luben R, Biggs M . Differential white blood cell count and type 2 diabetes: systematic review and meta-analysis of cross-sectional and prospective studies. PLoS One. 2010; 5(10):e13405. PMC: 2956635. DOI: 10.1371/journal.pone.0013405. View

12.

Kaur R, Kaur M, Singh J . Endothelial dysfunction and platelet hyperactivity in type 2 diabetes mellitus: molecular insights and therapeutic strategies. Cardiovasc Diabetol. 2018; 17(1):121. PMC: 6117983. DOI: 10.1186/s12933-018-0763-3. View

13.

Morel O, Jesel L, Abbas M, Morel N . Prothrombotic changes in diabetes mellitus. Semin Thromb Hemost. 2013; 39(5):477-88. DOI: 10.1055/s-0033-1343888. View

14.

Vagdatli E, Gounari E, Lazaridou E, Katsibourlia E, Tsikopoulou F, Labrianou I . Platelet distribution width: a simple, practical and specific marker of activation of coagulation. Hippokratia. 2010; 14(1):28-32. PMC: 2843567. View

15.

Abdel-Moneim A, Zanaty M, El-Sayed A, Khalil R, Rahman H . Relation Between Oxidative Stress and Hematologic Abnormalities in Children With Type 1 Diabetes. Can J Diabetes. 2019; 44(3):222-228. DOI: 10.1016/j.jcjd.2019.07.153. View

16.

Ferroni P, Basili S, Falco A, Davi G . Platelet activation in type 2 diabetes mellitus. J Thromb Haemost. 2004; 2(8):1282-91. DOI: 10.1111/j.1538-7836.2004.00836.x. View

17.

Habteyohans B, Hailu B, Meseret F, Mohammed A, Berhanu Y, Alemu A . Poor glycemic control and its associated factors among children with type 1 diabetes mellitus in Harar, eastern Ethiopia: A cross-sectional study. BMC Endocr Disord. 2023; 23(1):208. PMC: 10538014. DOI: 10.1186/s12902-023-01453-9. View

18.

Sobu E, Demir Yenigurbuz F, Ozcora G, Kole M . Evaluation of the Impact of Glycemic Control on Mean Platelet Volume and Platelet Activation in Children with Type 1 Diabetes. J Trop Pediatr. 2022; 68(4). DOI: 10.1093/tropej/fmac063. View

19.

Haris B, Ahmed I, Syed N, Almabrazi H, Saraswathi S, Al-Khawaga S . Clinical features, epidemiology, autoantibody status, HLA haplotypes and genetic mechanisms of type 1 diabetes mellitus among children in Qatar. Sci Rep. 2021; 11(1):18887. PMC: 8460652. DOI: 10.1038/s41598-021-98460-4. View

20.

Urbano F, Farella I, Brunetti G, Faienza M . Pediatric Type 1 Diabetes: Mechanisms and Impact of Technologies on Comorbidities and Life Expectancy. Int J Mol Sci. 2023; 24(15). PMC: 10418611. DOI: 10.3390/ijms241511980. View